AP
Atul Pande (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Immunovant, Inc. (IMVT). The largest single filing was $192K of IMVT (6,000 sh × $32.00, as filed), executed May 20. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$192K
shares × price, as filed
Last traded
May 20
Filed May 20
Median ADV $75.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $413K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
IMVTRecent filings
IMVTSALE
Immunovant, Inc.
View filing →
$192K6,000 sh × $32.00
Exec May 20
Filed May 20 · 5:30 PM ET IMVTSALE Immunovant, Inc. View filing → $221K
7,750 sh × $28.54
Exec Dec 2 2024
Filed Dec 4 2024 · 5:30 PM ET